phenylbutazone has been researched along with Bone Loss, Osteoclastic in 2 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haddad, JG | 1 |
| Hanson, CA | 1 |
| Shagrin, JW | 1 |
| Duncan, H | 1 |
1 review available for phenylbutazone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Paget's disease of bone: problems and management.
Topics: Adrenocorticotropic Hormone; Alkaline Phosphatase; Aspirin; Bone Regeneration; Bone Resorption; Calc | 1972 |
1 other study available for phenylbutazone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Vertebral osteoporosis in ankylosing spondylitis.
Topics: Adult; Aged; Biopsy; Bone Resorption; Female; Fractures, Spontaneous; Haversian System; Humans; Male | 1971 |